Molecular comparison between peritoneal metastases (PM) and primary gastric (GC) and gastroesophageal junction (GEJ) cancer.

Authors

null

Matthew K Stein

West Cancer Center, U Tennessee, Memphis, TN

Matthew K Stein , Joanne Xiu , Michael Gary Martin , Axel Grothey , Philippe Prouet , Jeffrey Owsley , Forrest W Williard , Evan Scott Glazer , Paxton Vandiver Dickson , David Shibata , Danny Yakoub , Richard M. Goldberg , W. Michael Korn , Anthony Frank Shields , Jimmy J. Hwang , Heinz-Josef Lenz , Jeremiah Lee Deneve

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4053)

DOI

10.1200/JCO.2019.37.15_suppl.4053

Abstract #

4053

Poster Bd #

158

Abstract Disclosures

Similar Posters

First Author: Kristina Fanucci

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer.

Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer.

First Author: Ryan H. Moy

Poster

2022 ASCO Genitourinary Cancers Symposium

Impact of PD-L1 expression on conventional urothelial bladder carcinoma (UBC) genomic alteration (GA) profile.

Impact of PD-L1 expression on conventional urothelial bladder carcinoma (UBC) genomic alteration (GA) profile.

First Author: Petros Grivas

Poster

2021 ASCO Annual Meeting

HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.

HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.

First Author: Tenley Klc